Juvenile Dermatomyositis

Overview

This is a retrospective descriptive cross-sectional and observational multicenter clinical and progressive study of juvenile dermatomyositis. The aim is to determine the clinical, paraclinical, and evolutive characteristics and therapeutic modalities from a series of juvenile dermatomyositis identified in Alsace between 2000 to 2015.

Full Title of Study: “Retrospective Descriptive Study of Juvenile Dermatomyositis in Alsace”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Retrospective
  • Study Primary Completion Date: January 2019

Clinical Trial Outcome Measures

Primary Measures

  • Study of clinical characteristics of juvenile dermatomyositis
    • Time Frame: The period from from January 1st, 2000 to December 31st, 2015 will be examined

Participating in This Clinical Trial

Inclusion Criteria

  • Age under 16 years – Have a dermatomyositis according to the diagnostic criteria of Bohan and Peter of 1975 Exclusion Criteria:

  • Refusal to participate in the study

Gender Eligibility: All

Minimum Age: 1 Day

Maximum Age: 16 Years

Investigator Details

  • Lead Sponsor
    • University Hospital, Strasbourg, France
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Contact(s)
    • Dan LIPSKER, MD, PhD, 33.3.88.11.61.79, dan.lipsker@chru-strasbourg.fr

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.